Summary
The immune system is a complex network and inadvertent immunological reactivity can result in HYPERSENSITIVITY or autoimmunity. Nearly every chemical can induce HYPERSENSITIVITY reactions which can affect nearly every organ or tissue of the body. One organ or tissue, however, is often a predominant target. Anaphylactic shock, skin reactions, and cytopenias are the most frequent reactions. HYPERSENSITIVITY reactions can be either immunemediated or non-immune-mediated (pseudoallergy). A number of different mechanisms are involved and risk factors can serve as triggers. Autoimmunity is still a mystery even though autoimmune diseases are relatively common. Spontaneous autoimmune diseases as well as drug- and chemical-induced autoimmune reactions are divided into systemic and organ-specific. Our current understanding of the mechanisms involved in these adverse reactions is very limited.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected readings
Descotes J (ed.) (2004) Immunotoxicity of Drugs and Chemicals: An Experimental and Clinical Approach. Vol. 1: Principles and Methods of Immunotoxicology. Elsevier, Amsterdam
Holgate ST, Church MK, Lichtenstein LM (2000) Allergy (2nd Edition). Mosby, London
Gorski A, Krotkiewski H, Zimecki M (2001) Autoimmunity. Kluwer Academic Publishers, Dordrecht, Boston
References
Descotes J (2004) Health consequences of immunotoxic effects. In: Descotes J (ed): Immunotoxicity of Drugs and Chemicals, 3rd edition. Elsevier, Amsterdam, 55–126
Demoly P, Bousquet J (2001) Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 1: 305–310
Choquet-Kastylevsky G, Vial T, Descotes J (2001) Drug allergy diagnosis in humans: possibilities and pitfalls. Toxicology 158: 1–10
Bochner BS, Lichtenstein LM (1991) Anaphylaxis. N Engl J Med 324: 1785–1790
Klein JS, Yocum MN (1995) Underreporting of anaphylaxis in a community emergency room. J Clin Allergy Immunol 95: 637–638
Gruchalla RS (2003) Drug allergy. J Allergy Clin Immunol 111(Suppl): 548–559
Greenberger PA (1999) Allergic emergencies in the physician’s office. Clin Rev Allergy Immunol 17: 401–412
Wolkenstein P, Revuz J (1995) Drug-induced severe skin reactions. Drug Saf 13: 56–68
Svensson CR, Cowen EW, Gaspari AA (2000) Cutaneous drug reactions. Pharmacol Rev 53: 357–379
Pichler W, Yawalkar N, Schmid S, Helbling A (2002) Pathogenesis of drug-induced exanthems. Allergy 57: 884–893
Andersen KE, Maibach HI (1980) Allergic reaction to drugs used topically. Clin Toxicol 16: 415–465
Fritsch PO, Sidoroff A (2000) Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol 1: 349–360
Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F et al (1995) Medication and risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333: 1600–1607
Bocquet H, Bagot M, Roujeau JC (1996) Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 15: 250–257
Danielson DA, Douglas SW, Herzog J, Jick H, Porter JB (1984) Drug-induced blood disorders. JAMA 252: 3257–3260
Salama A, Mueller-Eckhardt C (1986) Two types of nomifensine-induced immune haemolytic anaemias: drug-dependent sensitization and/or autoimmunization. Br J Haematol 64: 613–620
Thompson JW, Jacobs RF (1993) Adverse effects of newer cephalosporins. An update. Drug Saf 9: 132–142
Warkentin TE (2002) Heparin-induced thrombocytopenia. Curr Hematol Rep 1: 63–72
Liu ZX, Kaplowitz N (2002) Immune-mediated drug-induced liver disease. Clin Liver Dis 6: 467–486
Alexopoulos E (1998) Drug-induced acute interstitial nephritis. Renal Failure 20: 809–819
Limper AH, Rosenow EC (1996) Drug-induced interstitial lung disease. Curr Opin Pulm Med 2: 396–404
Park BK, Naisbitt DJ, Gordon SF, Kitteringham NR, Pirmohamed M (2001) Metabolic activation in drug allergies. Toxicology 158: 11–23
The International Collaborative Study of Severe Anaphylaxis (1998) An epidemiological study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks. Epidemiology 9: 141–146
Baldo BA, Pham NH, Zhao Z (2001) Chemistry of drug allergenicity. Curr Opin Allergy Clin Immunol 1: 327–335
Descotes J, Choquet-Kastylevsky G (2001) The Gell and Coombs classification: is it still valid? Toxicology 158: 43–49
Rajan TV (2003) The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation. Trends Immunol 24: 376–379
Pichler WJ (2003) Delayed drug hypersensitivity reactions. Ann Intern Med 139: 683–693
Zuberbier T (1999) Pseudoallergy or nonallergic hypersensitivity. Allergy 54: 397–398
Wallace MR, Mascola JR, Oldfield EC (1991) Red man syndrome: incidence, etiology, and prophylaxis. J Infect Dis 164: 1180–1185
Szebeni J (2001) Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents. Crit Rev Ther Drug Carrier Syst 18: 567–606
Szczeklik A, Stevenson DD (2003) Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111: 913–921
Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffre D, Nussberger J (1999) Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology 4: 21–25
Jacobson DL, Gange SJ, Rose NR, Graham NM (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84: 223–243
Bigazzi PE (1997) Auto-immunity induced by xenobiotics. Toxicology 119: 1–21
Vial T, Nicolas B, Descotes J (1997) Drug-induced autoimmunity. Experience of the French Pharmacovigilance system. Toxicology 119: 23–27
Vial T, Chevrel G, Descotes J (2000) Drugs acting on the immune system. In: MNG Dukes, JK Aronson (eds): Meyler’s Side-Effects of Drugs, 14th edition. Elsevier Sciences, Amsterdam, 1246–1337
Rubin RL (1999) Etiology and mechanisms of druginduced lupus. Curr Opin Rheumatol 11: 357–363
Behan PO, Behan WM, Zacharias FJ, Nicholls JT (1976) Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet 2: 984–987
Piyasirisilp S, Hemachudha T (2002) Neurological adverse events associated with vaccination. Curr Opin Neurol 15: 333–338
Penn AS, Low BW, Jaffe IA, Luo L, Jacques JJ (1998) Drug-induced autoimmune myasthenia gravis. Ann NY Acad Sci 841: 433–449
Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Engl J Med 348: 2646–2655
Beaune PH, Lecoeur S (1997) Immunotoxicology of the liver: adverse reactions to drugs. J Hepatol 26(Suppl 2): 37–42
Miossec P (1997) Cytokine-induced autoimmune disorders. Drug Saf 17: 93–104
Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR (2001) From infection to autoimmunity. J Autoimmun 16: 175–186
Pichler WJ (2003) Drug-induced autoimmunity. Curr Opin Allergy Clin Immunol 3: 249–253
Choquet-Kastylevsky G, Descotes J (1998) Value of animal models for predicting hypersensitivity reactions to medicinal products. Toxicology 129: 27–35
Descotes J (2000) Autoimmunity and toxicity testing. Toxicol Lett 112—113: 461–465
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Birkhäuser Verlag
About this chapter
Cite this chapter
Descotes, J., Vial, T. (2005). Immune response in human pathology: hypersensitivity and autoimmunity. In: Nijkamp, F.P., Parnham, M.J. (eds) Principles of Immunopharmacology. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7408-X_8
Download citation
DOI: https://doi.org/10.1007/3-7643-7408-X_8
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-5804-4
Online ISBN: 978-3-7643-7408-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)